Amae Health Develops New Protocols and Technology for Severe Mental Illness Care
Amae Health, a Series B, venture-backed Public Benefit Corporation, is actively developing clinical protocols, measurement science, and technology to deliver coordinated longitudinal outpatient care for individuals with severe mental illness in the United States. These conditions include schizophrenia, schizoaffective disorder, Bipolar I, and treatment-resistant depression, which affect over 15 million adults. The company operates high-acuity, in-person clinics nationwide, integrating psychiatry, therapy, primary care, dietitians, and community support under one roof. Amae Health collaborates with leading health systems such as NewYork-Presbyterian, Cedars-Sinai, Mass General Brigham, Novant Health, and CommonSpirit to expand this level of specialized care. The organization is also building proprietary clinical protocols, novel measurement tools, and an AI-driven data platform specifically designed for severe mental illness, aiming to create a care model that has not previously existed.